Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Boughey

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nursing Times|May 12, 1993
Open learning. Quantum leapP Cain, J Boughey
Neuropsychobiology|January 1, 1992
Cognitive and psychomotor function during severe insulin-induced hypoglycaemia in insulin-dependent diabetic patientsT Lingenfelser, D Overkamp, W Renn, et al.
Nurse Education Today|May 21, 2022
Development of a spiritual care education matrix: Factors facilitating/hindering improvement of spiritual care competency in student nurses and midwivesLinda Ross, Tove Giske, Adam J Boughey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2021
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapyL Du, C Yau, L Brown-Swigart, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nursing Times|May 12, 1993
Open learning. Quantum leapP Cain, J Boughey
Neuropsychobiology|January 1, 1992
Cognitive and psychomotor function during severe insulin-induced hypoglycaemia in insulin-dependent diabetic patientsT Lingenfelser, D Overkamp, W Renn, et al.
Nurse Education Today|May 21, 2022
Development of a spiritual care education matrix: Factors facilitating/hindering improvement of spiritual care competency in student nurses and midwivesLinda Ross, Tove Giske, Adam J Boughey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2021
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapyL Du, C Yau, L Brown-Swigart, et al.
Pageof 1